|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/56 | |
| A61K 31/70 | |||
| A61K 31/713 |
| (11) | Patento numeris | 2231195 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08865121.1 |
| Europos patento paraiškos padavimo data | 2008-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/085582 |
| Data | 2008-12-04 |
| (87) | Numeris | WO 2009/082607 |
| Data | 2009-07-02 |
| (30) | Numeris | Data | Šalis |
| 992309 P | 2007-12-04 | US | |
| 127751 P | 2008-05-14 | US | |
| 91093 P | 2008-08-22 | US | |
| 97261 P | 2008-09-16 | US | |
| 13597 P | 2007-12-13 | US |
| (72) |
MANOHARAN, Muthiah, US
RAJEEV, Kallanthottathil, G., US
NARAYANANNAIR, Jayaprakash, K., US
JAYARAMAN, Muthusamy, US
|
| (73) |
Arbutus Biopharma Corporation,
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8,
CA
|
| (54) | TARGETING LIPIDS |
| TARGETING LIPIDS |